bioRxivBiochemistry
Changes in the urinary proteome in a Patient-Derived Xenograft model
Abstract
In this report, the urinary proteome from a patient-derived xenograft (PDX) model was compared at the peptide level to study the origins of urinary proteins in tumor-bearing nude mice. Urine was collected from the PDX mice before and after tumor implantation. A total of 515 mouse proteins were identified, of which 8 were differential proteins. Seventy-eight unambiguous human peptides from 42 human proteins were identified in the tumor-bearing group. Compared with the differential urinary proteins from the tumor-bearing immuno-competent rats, the differential proteins in the urine from the PDX model had no host immune response proteins in the very early stage urine in the tumor-bearing immuno-competent rat model.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dynamic changes in the urine proteome of tumor-bearing mouse models of B16 melanoma and RM-1 prostate cancer
- Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model
L. Zhang, Y. Li, … Y. Gao·Cancer MedicinePeer-reviewed·May 15, 2019
- Early changes in the urine proteome in a rat liver tumor model
- Comparison of urine proteomes from tumor-bearing mice with those from tumor-resected mice
- Early urinary protein changes in the tumor-forming process of the NuTu-19 lung metastasis
- Urine proteome changes in rats with approximately ten tumor cells subcutaneous inoculation.